Hester Biosciences Limited has informed the Exchange regarding Appointment of Mr. Ashish Desai as Chief Financial Officer of the company w.e.f. November 20, 2025.
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hester Biosciences Limited has announced the appointment of Mr. Ashish Desai as the new Chief Financial Officer of the company, effective November 20, 2025. This is a key managerial personnel appointment filling the CFO role. The announcement is a routine corporate disclosure made to the NSE regarding the change in the company's senior finance leadership. No further details about the appointee's background or terms of appointment were provided in the filing.
For shareholders, this is a routine leadership update that brings a new CFO into the finance function, which may signal fresh strategic direction in financial management but is unlikely to cause immediate stock price movement on its own.